Development of squamous cell carcinomas in Darier disease: a new model for skin carcinogenesis?
Alexandrescu
D T
DT
Dasanu
C A
CA
Farzanmehr
H
H
Kauffman
C L
CL
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000473:pathology* / Q000556:secondary / Q000628:therapy; D000068818:Cetuximab; D007644:Darier Disease / Q000473:pathology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012878:Skin Neoplasms / Q000473:pathology* / Q000556:secondary / Q000628:therapy; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068818:Cetuximab